Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Prevention Of Shwartzman’S Phenomenon In Factor XIII Deficiency

View through CrossRef
Cross-linked clots formed in vitro are reported to be more resistant to fibrinolysis but the relevance of these observations to the situation in vivo is uncertain. The possible role of Factor XIII in the formation of diffuse intravascular fibrin deposition was examined in experimentally induced Factor XIII deficient rabbits. Factor XIII deficiency was induced by intravenous infusion of IgG isolated from goat anti-rabbit platelet Factor XIII. Control received normal goat IgG. The Shwartzman reaction was produced by two injections of bacterial endotoxin given 24 hours apart.The most striking histological differences were observed after 48 hours. A large number of glomerular loops were enlarged and engorged with red blood cells and platelet- fibrin thrombi; extensive bilateral cortical necrosis was observed in 8 out of 10 endotoxin injected control rabbits but none in the Factor XIII deficient group.Fibrinogen levels in control rabbits were increased 3-4 fold (1.1g/100 ml), at 24 hours and slightly decreased at 48 hours after endotoxin injection, whereas in Factor XIII deficient animals, the rate of increase was slower but reached similar levels at 48 hours. Fibrinolytic activity in vivo, studied by the degradation of infused 125I-fibrinogen, was significantly increased in both endotoxin injected groups, irrespective of Factor XIII levels.These results strongly suggest that cross-linked thrombi are more resistant to fibrinolysis in vivo as well as in vitro.
Title: Prevention Of Shwartzman’S Phenomenon In Factor XIII Deficiency
Description:
Cross-linked clots formed in vitro are reported to be more resistant to fibrinolysis but the relevance of these observations to the situation in vivo is uncertain.
The possible role of Factor XIII in the formation of diffuse intravascular fibrin deposition was examined in experimentally induced Factor XIII deficient rabbits.
Factor XIII deficiency was induced by intravenous infusion of IgG isolated from goat anti-rabbit platelet Factor XIII.
Control received normal goat IgG.
The Shwartzman reaction was produced by two injections of bacterial endotoxin given 24 hours apart.
The most striking histological differences were observed after 48 hours.
A large number of glomerular loops were enlarged and engorged with red blood cells and platelet- fibrin thrombi; extensive bilateral cortical necrosis was observed in 8 out of 10 endotoxin injected control rabbits but none in the Factor XIII deficient group.
Fibrinogen levels in control rabbits were increased 3-4 fold (1.
1g/100 ml), at 24 hours and slightly decreased at 48 hours after endotoxin injection, whereas in Factor XIII deficient animals, the rate of increase was slower but reached similar levels at 48 hours.
Fibrinolytic activity in vivo, studied by the degradation of infused 125I-fibrinogen, was significantly increased in both endotoxin injected groups, irrespective of Factor XIII levels.
These results strongly suggest that cross-linked thrombi are more resistant to fibrinolysis in vivo as well as in vitro.

Related Results

Whatever happened to the Shwartzman phenomenon?
Whatever happened to the Shwartzman phenomenon?
Ninety years ago, Gregory Shwartzman first reported an unusual discovery following the intradermal injection of sterile culture filtrates from principally Gram-negative strains fro...
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Clinical Implications of Cytopenias in the U.S. Immunodeficiency Network Registry
Rationale The correlation between cytopenias and infection, malignancy, and mortality has not been systematically characterized in patients with inborn errors of ...
Interactions of Factor XIII Subunits as Studied by Affinity Chromatography
Interactions of Factor XIII Subunits as Studied by Affinity Chromatography
A new method for studying the interactions of plasma factor XIII subunits, as well as purifying both plasma and platelet factor XIII, has been developed using an organomer-curial l...
Neutralization of the Shwartzman Reactions by Polymyxin B
Neutralization of the Shwartzman Reactions by Polymyxin B
Summary Polymyxin B prevented the localized Shwartzman reaction in rabbits when admixed with the intravenous (i.v.) provocative dose of endotoxin but enhanced the re...
A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII
A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII
AbstractCongenital factor XIII (FXIII) deficiency is an extremely rare hemorrhagic disorder characterized by a deficiency of FXIII and associated with a high rate of morbidity and ...
Factor V Inhibitor in COVID-19 an Unusual Presentation
Factor V Inhibitor in COVID-19 an Unusual Presentation
Introduction : A huge variety of haematological manifestations and derangements have been frequently published with COVID-19 infections, however Factor V deficiency and COVID-19 in...
Factor XII Deficiency in ECMO Patients
Factor XII Deficiency in ECMO Patients
Background: Extracorporeal membrane oxygenation (ECMO) for cardiopulmonary support of critically ill patients is used frequently in the pediatric and adult population. Although a l...

Back to Top